Press Releases

04.11.2019
Ophthotech Obtains Exclusive Global License to AAV Gene Therapy Program for BEST1 Related Retinal Diseases
03.14.2019
Ophthotech to Present at the Alliance for Regenerative Medicine’s (ARM) 7th Annual Cell & Gene Therapy Investor Day
03.06.2019
Ophthotech to Present at the Cowen and Company 39th Annual Health Care Conference
02.26.2019
Ophthotech Reports Fourth Quarter and Full Year 2018 Financial and Operating Results
02.19.2019
Ophthotech Corporation to Report Fourth Quarter and Full Year 2018 Financial Results and Host Conference Call on Tuesday, February 26, 2019
01.03.2019
Ophthotech Corporation to Present at the 37th Annual J.P. Morgan Healthcare Conference
01.02.2019
Ophthotech Announces the Addition of Ophthalmic Industry Leader, Calvin (Cal) W. Roberts, M.D., to Its Board of Directors
12.12.2018
Ophthotech Announces the Addition of Ophthalmic Industry Leader, Adrienne L. Graves, Ph.D., Former Chief Executive Officer of Santen Inc., to Its Board of Directors
11.12.2018
Ophthotech Announces Results from Phase 2a Safety Trial of Zimura® in Combination with Lucentis® in Wet Age-Related Macular Degeneration
10.31.2018
Ophthotech Reports Third Quarter 2018 Financial and Operating Results